Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC933128216;28217;28218 chr2:178711245;178711244;178711243chr2:179575972;179575971;179575970
N2AB901427265;27266;27267 chr2:178711245;178711244;178711243chr2:179575972;179575971;179575970
N2A808724484;24485;24486 chr2:178711245;178711244;178711243chr2:179575972;179575971;179575970
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: TCC
  • RefSeq wild type template codon: AGG
  • Domain: Ig-79
  • Domain position: 31
  • Structural Position: 45
  • Q(SASA): 0.5311
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/A None None 0.019 None 0.179 0.1 0.1749357433 gnomAD-4.0.0 1.36836E-06 None None None None I None 2.98757E-05 0 None 0 0 None 0 0 8.99457E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0724 likely_benign 0.0775 benign -0.665 Destabilizing 0.019 N 0.179 neutral None None None None I
S/C 0.159 likely_benign 0.1733 benign -0.499 Destabilizing 0.946 D 0.454 neutral None None None None I
S/D 0.171 likely_benign 0.2298 benign 0.386 Stabilizing 0.055 N 0.231 neutral None None None None I
S/E 0.1744 likely_benign 0.2443 benign 0.36 Stabilizing None N 0.097 neutral None None None None I
S/F 0.1352 likely_benign 0.1418 benign -1.171 Destabilizing 0.602 D 0.513 neutral None None None None I
S/G 0.0973 likely_benign 0.1143 benign -0.839 Destabilizing 0.104 N 0.241 neutral None None None None I
S/H 0.1555 likely_benign 0.1846 benign -1.196 Destabilizing 0.497 N 0.475 neutral None None None None I
S/I 0.1003 likely_benign 0.1168 benign -0.319 Destabilizing 0.124 N 0.411 neutral None None None None I
S/K 0.243 likely_benign 0.3405 ambiguous -0.341 Destabilizing 0.055 N 0.245 neutral None None None None I
S/L 0.0891 likely_benign 0.0875 benign -0.319 Destabilizing 0.055 N 0.328 neutral None None None None I
S/M 0.1432 likely_benign 0.1446 benign -0.264 Destabilizing 0.667 D 0.474 neutral None None None None I
S/N 0.0855 likely_benign 0.1027 benign -0.334 Destabilizing 0.104 N 0.242 neutral None None None None I
S/P 0.65 likely_pathogenic 0.7308 pathogenic -0.404 Destabilizing 0.301 N 0.421 neutral None None None None I
S/Q 0.2039 likely_benign 0.2589 benign -0.415 Destabilizing 0.001 N 0.127 neutral None None None None I
S/R 0.2013 likely_benign 0.2764 benign -0.253 Destabilizing 0.124 N 0.417 neutral None None None None I
S/T 0.0602 likely_benign 0.0664 benign -0.398 Destabilizing 0.001 N 0.131 neutral None None None None I
S/V 0.1154 likely_benign 0.1306 benign -0.404 Destabilizing None N 0.281 neutral None None None None I
S/W 0.2313 likely_benign 0.2857 benign -1.168 Destabilizing 0.958 D 0.478 neutral None None None None I
S/Y 0.1214 likely_benign 0.1393 benign -0.86 Destabilizing 0.602 D 0.547 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.